Ferinject 1000mg Injection (20ml) contains the active ingredient Ferric carboxymaltose, which belongs to a class of medications known as iron replacement therapies. It is primarily used to treat iron-deficiency anemia—a condition characterized by reduced red blood cell count due to insufficient iron levels in the body. This medication is recommended for adults and pediatric patients over one year of age who are unable to tolerate oral iron supplements or for whom oral therapy has proven ineffective. It is also used in adults with chronic kidney disease not undergoing dialysis to correct iron deficiency anemia.
Ferinject should not be used in individuals who are allergic to ferric carboxymaltose or any of the other components in the formulation. Additionally, it is not suitable for patients with anemia unrelated to iron deficiency, iron overload disorders, or impairments in iron utilization. Patients should inform their physician if they have conditions such as rheumatoid arthritis, severe asthma, eczema, active infections, liver diseases, or low phosphate levels in the blood, as these may influence the safety and efficacy of the treatment.
The injection must be administered correctly by a healthcare professional, as improper administration may lead to injection site irritation or permanent discoloration. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your doctor before beginning treatment.
Common side effects associated with Ferinject include nausea, high blood pressure, facial flushing, skin reactions, dizziness, vomiting, and reactions at the injection site. If you have had a serious allergic reaction to any injectable iron therapy in the past, make sure your doctor is aware before receiving this injection.
